|
|
Volumn 55, Issue 3, 1998, Pages 210-
|
|
Roche, FDA announce new drug interaction warnings for mibefradil
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CYCLOSPORIN;
CYTOCHROME P450;
MEVINOLIN;
MIBEFRADIL;
SIMVASTATIN;
TACROLIMUS;
BRADYCARDIA;
DRUG ANTAGONISM;
DRUG INFORMATION;
DRUG LABELING;
DRUG MARKETING;
DRUG TRANSPORT;
ENZYME INHIBITION;
HUMAN;
NOTE;
PRIORITY JOURNAL;
RHABDOMYOLYSIS;
|
|
EID: 85077295695
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/55.3.210a Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|